Active substance
Droxidopa
- US FDA 17
- US price lines 3
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NORTHERA | 100MG; 200MG; 300MG | capsule · oral | LUNDBECK NA LTD | Prescription | 18 Feb 2014 |
| DROXIDOPA | 300MG; 100MG; 200MG | capsule · oral | ANNORA | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | MSN PHARMS INC | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | ZYDUS PHARMS | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | ALKEM LABS LTD | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | SCIEGEN PHARMS | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | SUN PHARM | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | AUROBINDO PHARMA LTD | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | JUBILANT CADISTA | Prescription | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | BIONPHARMA | Prescription | 28 Apr 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | SOMERSET THERAPS LLC | Prescription | 5 May 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | ADAPTIS | Prescription | 1 Nov 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | LUPIN PHARMS | Discontinued | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | HIKMA PHARMS | Discontinued | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | TEVA PHARMS USA INC | Discontinued | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | UPSHER SMITH LABS | Discontinued | 18 Feb 2021 |
| DROXIDOPA | 100MG; 200MG; 300MG | capsule · oral | CHARTWELL RX | Discontinued | 5 May 2022 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DROXIDOPA 100 MG CAPSULE | $0.47244 | per EA | 23 Sep 2026 |
| US NADAC | DROXIDOPA 200 MG CAPSULE | $0.9008 | per EA | 23 Sep 2026 |
| US NADAC | DROXIDOPA 300 MG CAPSULE | $1.84448 | per EA | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 10 Feb 2017 NORTHERA — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.